VASCEPA was associated with an increased risk (3% vs 2%) of atrial fibrillation or atrial flutter requiring hospitalization ...

NovaBridge Biosciences announced updated results from the Phase 1b study of givastomig, a bispecific antibody targeting ...

U.S. FDA-approved Indications Libtayo is a prescription medicine used to treat: ...

ULTRALIFE lobbying was just disclosed, from Q3 of 2026, in a new Lobbying Disclosure Act filing. This included lobbying on ...

Pumitamig plus docetaxel demonstrated a confirmed objective response rate of 36.7% in patients with non-small cell lung ...

Jeffries criticizes Trump’s remarks: House Democratic Leader Hakeem Jeffries said Donald Trump had “consistently” used “vile ...

Figures seeks disaster declaration: Congressman Shomari C. Figures said he sent a letter to President Trump asking the White ...

In a separate case study presented yesterday, one patient with frequently relapsing MCD received 100 mg of budoprutug. The patient experienced three-year steroid-free remission and remained in ...

Reps. Don Bacon, Brian Fitzpatrick and Marie Gluesenkamp Perez introduced the “Ronald Reagan Peace Through Strength Act of 2026,” saying it would reinforce the U.S. ban on Russian energy imports and ...

Parabilis Medicines reports promising zolucatetide data, showing high response rates and plans for a Phase 3 trial in 2027.

Immatics reports promising anti-tumor activity and safety of IMA402 and IMA203CD8 in advanced cancers, supporting further development.

Steube backs bridge funding request: Rep. Greg Steube said he sent a letter to the Federal Highway Administration supporting ...